Research graph
References from Les antiépileptiques thymorégulateurs dans le traitement des symptômes comportementaux et psychologiques de la démence (SCPD). Local targets link to admitted publications; unresolved targets remain external evidence.
Carbamazepine in senile dementia and overactivity – a placebo-controlled double blind trial
1982 · External reference
Combination of donepezil and gabapentin for behavioral disorders in Alzheimer's disease
10.4088/jcp.v61n0114f · 2000 · External reference
Treatment of psychotic symptoms with lamotrigine in Alzheimer disease
10.1097/01.jcp.0000117431.83724.b0 · 2004 · External reference
Aggression in dementia with lamotrigine treatment
10.1176/appi.ajp.157.7.1178 · 2000 · External reference
Carbamazepine in dementia
10.1097/00004714-198608000-00007 · 1986 · External reference
Fortnightly review: drug treatment of epilepsy
10.1136/bmj.318.7176.106 · 1999 · External reference
Treatment of aggressive behaviour in dementia with the anticonvulsant topiramate: a retrospective pilot study
10.1017/s1041610203009554 · 2003 · External reference
Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics
1990 · External reference
Divalproex: a possible alternative for demented, elderly aggressive patients
10.3109/10401239709147789 · 1997 · External reference
A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias
10.1176/appi.ajgp.8.3.221 · 2000 · External reference
Hyponatremia due to sodium valproate
2005 · External reference
Valproic acid treatment of agitation in dementia
10.1177/070674379804300108 · 1998 · External reference
Effectiveness of gabapentin for the treatment of behavioral disorders in dementia
10.1097/00004714-200002000-00015 · 2000 · External reference
A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease
10.1159/000097757 · 2007 · External reference
Valproate-induced parkinsonism in a demented elderly patient
10.4088/jcp.v63n0114a · 2002 · External reference
The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances
10.1002/(sici)1099-1166(199801)13:1<29::aid-gps726>3.0.co;2-z · 1998 · External reference
GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target fot the treatment of behavioural and psychological symptoms of dementia
10.1177/070674370404900705 · 2004 · External reference
Prise en charge des troubles du comportement dans les démences
2000 · External reference
Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review
10.1136/bmj.38125.465579.55 · 2004 · External reference
Carbamazepine treatment of agitation associated with dementia
10.1177/089198878800100208 · 1988 · External reference
Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics
1995 · External reference
10.1002/14651858.cd003945.pub2
10.1002/14651858.cd003945.pub2 · External reference
Valproate in the treatment of behavioral agitation in elderly patients with dementia
10.1176/jnp.7.3.314 · 1995 · External reference
Gabapentin for the management of agitation
10.1097/00004714-199910000-00020 · 1999 · External reference
Neuroprotective properties of valproate: potential benefit for AD and tauopathies
10.1385/jmn:19:3:301 · 2002 · External reference
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
10.1212/wnl.52.2.321 · 1999 · External reference
Sodium valproate in the treatment of behavioral disturbance in dementia
10.1177/089198879300600404 · 1993 · External reference
Gabapentin for treatment of behavioral and psychological symptoms of dementia
10.1345/aph.10217 · 2001 · External reference
Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation
10.2165/00002512-200320140-00003 · 2003 · External reference
Treatment of dementia with behavioral disturbance using valproex or a combination of divalproex and a neuroleptic
10.4088/jcp.v58n0804 · 1997 · External reference
A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease
10.1097/00019442-200111000-00008 · 2001 · External reference
A preliminary study of carbamazepine in the treatment of assaultive patients with dementia
10.1177/089198878800100105 · 1988 · External reference
An open trial of valproate for agitation in geriatric neuropsychiatric disorders
10.1097/00019442-199700540-00010 · 1997 · External reference
Placebo-controlled study of divalproex sodium for agitation in dementia
10.1176/appi.ajgp.9.1.58 · 2001 · External reference
Valproate therapy for agitation in dementia: extension of a double-blind trial
10.1176/appi.ajgp.11.4.434 · 2003 · External reference
A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease
10.2174/156720505774932205 · 2005 · External reference
Gabapentin and behavioral disorders in severe Alzheimer disease
10.1097/01.jcp.0000132447.65972.3d · 2004 · External reference
Gabapentin for behavioral agitation in Alzheimer's disease
10.1097/00004714-199702000-00015 · 1997 · External reference
Treatment of dementia-associated agitation with gabapentin
10.1176/jnp.12.1.40 · 2000 · External reference
The effects of sodium valproate on disturbed behaviour in dementia
10.1111/j.1532-5415.1994.tb06571.x · 1994 · External reference
Sodium valproate in the treatment of aggressive behaviour in patients with dementia – a randomized placebo-controlled clinical trial
10.1002/gps.653 · 2002 · External reference
Lamotrigin inhibits monoamin uptake in vitro and modulates 5-hydroxytryptamine uptake in rats
10.1016/s0014-2999(98)00580-9 · 1998 · External reference
Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study
10.1111/j.1532-5415.1994.tb06982.x · 1994 · External reference
Efficacy and tolerability of carbamazepine for agitation and aggression in dementia
10.1176/ajp.155.1.54 · 1998 · External reference
Safety and tolerability of divalproex sodium for the treatment of symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial
10.1016/s0011-393x(01)80042-4 · 2001 · External reference
Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales
10.1016/s0169-409x(02)00153-9 · 2002 · External reference
Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial
2005 · External reference
Effects of topiramate on cognitive function
10.1136/jnnp.69.5.636 · 2000 · External reference
